top of page
Introducing Bdparib Tablet (Rucaparib), a revolutionary medication for the treatment of ovarian cancer. This FDA-approved oral medication is designed to target tumor cells with a BRCA mutation, giving patients a new hope for managing their condition. The convenient tablet form makes it easy to integrate into a patient's daily routine, allowing for consistent and effective treatment. With its proven track record in clinical trials, Bdparib Tablet has been shown to significantly extend progression-free survival in patients with advanced ovarian cancer. Trust the power of Bdparib Tablet to make a difference in the lives of those battling ovarian cancer.

Bdparib Tablet (Rucaparib)

$660.00Price
Quantity
bottom of page